(redirected from injectable)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to injectable: injectable contraceptive
References in periodicals archive ?
On the basis of therapeutic application, the injectable drug delivery market is segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, and other diseases.
The global injectable drug delivery market has been segmented based on indication, formulations, device type and geography.
Forecasts Injectable drug product demand by indication and therapy to 2018
At baseline, women were classified according to whether they chose to initiate the injectable, oral contraceptives or no hormonal method.
Trends in injectable drug delivery dealmaking in the biopharma industry since 2010
Self-Injectable Specialty Drug Market Dynamics - Injectable Drug Demand Drivers - Drug Development Factors - Market Factors - Technology Factors - Self-Injection Product Design Factors - Ease-of-Use - Safety and Simplicity - Patient Interface - Competitive Landscape - Risks and Opportunities
Reviews the design of injectable biomaterials as well as their rheological properties and the mechanical properties of injectable polymers and composites
TechNavio's report, Global Facial Injectable Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts.
Injectable Drug Delivery Partnering 2010-2015 report provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the world's leading healthcare companies.
The Injectable Drug Ecosystem Injectable Drug Demand Drivers Drug Development Factors Market Factors Technology Factors Competitive Landscape Autoinjectors Needle-free Injectors Pen Injectors Prefilled Syringes Safety Syringes Risks and Opportunities
Alkermes currently has two commercial products: RISPERDAL([R]) CONSTA([R]) [(risperidone) long-acting injection], the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag (Janssen), a wholly owned division of Johnson & Johnson; and VIVITROL([R]) (naltrexone for extended-release injectable suspension) the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.
com/research/d8qj9s/european) has announced the addition of the "European Injectable Drug Delivery - Market Forecasts to 2017" report to their offering.